Cite

Mok T, Wu YL, Thongprasert S, Yang CH, Chu DT, Saijo N, et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med. 2009; 361(10); 947-957.MokTWuYLThongprasertSYangCHChuDTSaijoNGefitinib or carboplatin-paclitaxel in pulmonary adenocarcinomaN Engl J Med.20093611094795710.1056/NEJMoa081069919692680Search in Google Scholar

Nagashima O, Ohashi R, Yoshioka Y, Inagaki A, Tajima M Koinuma Y, et al. High prevalence of gene abnormalities in young patients with lung cancer. J Thorac Dis. 2013; 5(1): 27-30.NagashimaOOhashiRYoshiokaYInagakiATajimaMKoinumaYHigh prevalence of gene abnormalities in young patients with lung cancerJ Thorac Dis.2013512730Search in Google Scholar

Van den Bussche CJ, Illei PB, Lin MT, Ettinger DS, Maleki Z. Molecular alterations in non-small cell lung carcinoma of the young. Hum Pathol. 2014; 45(12): 2379-2387.Van den BusscheCJIlleiPBLinMTEttingerDSMalekiZ.Molecular alterations in non-small cell lung carcinoma of the youngHum Pathol.201445122379238710.1016/j.humpath.2014.08.00525288236Search in Google Scholar

Sacher AG, Dahlberg SE, Heng J, Mach S, Jänne PA, Oxnard GR. Lung cancer diagnosed in the young is associated with enrichment for targetable genomic alterations and poor prognosis. JAMA Oncol. 2016; 2(3): 313-320.SacherAGDahlbergSEHengJMachSJännePAOxnardGR.Lung cancer diagnosed in the young is associated with enrichment for targetable genomic alterations and poor prognosisJAMA Oncol.20162331332010.1001/jamaoncol.2015.4482481941826720421Search in Google Scholar

Nishi T, Yokose T, Miyagi Y, Daigo Y, Ito H, Isaka T, et al. Clinicopathological features and EGFR gene mutation status in elderly patients with resected nonsmall-cell lung cancer. BMC Cancer. 2014; 14: 610. 10.1186/1471-2407-14-610.NishiTYokoseTMiyagiYDaigoYItoHIsakaTClinicopathological features and EGFR gene mutation status in elderly patients with resected nonsmall-cell lung cancerBMC Cancer.20141461010.1186/1471-2407-14-610416191025152277Open DOISearch in Google Scholar

Shi Y, Au JS, Thongprasert S, Srinivasan S, Tsai CM, Khoa MT, et al. A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER). J Thorac Oncol. 2014; 9(2): 154-162.ShiYAuJSThongprasertSSrinivasanSTsaiCMKhoaMTA prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)J Thorac Oncol.20149215416210.1097/JTO.0000000000000033413203624419411Search in Google Scholar

eISSN:
1311-0160
Language:
English
Publication timeframe:
2 times per year
Journal Subjects:
Medicine, Basic Medical Science, other